BACKGROUND AND PURPOSE: The purpose of this study was to determine whether 74 single nucleotide polymorphisms (SNPs), which had been associated with coronary heart disease, are associated with incident ischemic stroke. METHODS: Based on antecedent studies of coronary heart disease, we prespecified the risk allele for each of the 74 SNPs. We used Cox proportional hazards models that adjusted for traditional risk factors to estimate the associations of these SNPs with incident ischemic stroke during 14 years of follow-up in a population-based study of older adults: the Cardiovascular Health Study (CHS). RESULTS: In white CHS participants, the prespecified risk alleles of 7 of the 74 SNPs (in HPS1, ITGAE, ABCG2, MYH15, FSTL4, CALM1, and BAT2) were nominally associated with increased risk of stroke (one-sided P<0.05, false discovery rate=0.42). In black participants, the prespecified risk alleles of 5 SNPs (in KRT4, LY6G5B, EDG1, DMXL2, and ABCG2) were nominally associated with stroke (one-sided P<0.05, false discovery rate=0.55). The Val12Met SNP in ABCG2 was associated with stroke in both white (hazard ratio, 1.46; 90% CI, 1.05 to 2.03) and black (hazard ratio, 3.59; 90% CI, 1.11 to 11.6) participants of CHS. Kaplan-Meier estimates of the 10-year cumulative incidence of stroke were greater among Val allele homozygotes than among Met allele carriers in both white (10% versus 6%) and black (12% versus 3%) participants of CHS. CONCLUSIONS: The Val12Met SNP in ABCG2 (encoding a transporter of sterols and xenobiotics) was associated with incident ischemic stroke in white and black participants of CHS.
BACKGROUND AND PURPOSE: The purpose of this study was to determine whether 74 single nucleotide polymorphisms (SNPs), which had been associated with coronary heart disease, are associated with incident ischemic stroke. METHODS: Based on antecedent studies of coronary heart disease, we prespecified the risk allele for each of the 74 SNPs. We used Cox proportional hazards models that adjusted for traditional risk factors to estimate the associations of these SNPs with incident ischemic stroke during 14 years of follow-up in a population-based study of older adults: the Cardiovascular Health Study (CHS). RESULTS: In white CHSparticipants, the prespecified risk alleles of 7 of the 74 SNPs (in HPS1, ITGAE, ABCG2, MYH15, FSTL4, CALM1, and BAT2) were nominally associated with increased risk of stroke (one-sided P<0.05, false discovery rate=0.42). In black participants, the prespecified risk alleles of 5 SNPs (in KRT4, LY6G5B, EDG1, DMXL2, and ABCG2) were nominally associated with stroke (one-sided P<0.05, false discovery rate=0.55). The Val12Met SNP in ABCG2 was associated with stroke in both white (hazard ratio, 1.46; 90% CI, 1.05 to 2.03) and black (hazard ratio, 3.59; 90% CI, 1.11 to 11.6) participants of CHS. Kaplan-Meier estimates of the 10-year cumulative incidence of stroke were greater among Val allele homozygotes than among Met allele carriers in both white (10% versus 6%) and black (12% versus 3%) participants of CHS. CONCLUSIONS: The Val12Met SNP in ABCG2 (encoding a transporter of sterols and xenobiotics) was associated with incident ischemic stroke in white and black participants of CHS.
Authors: Philippe R Desjardins; James M Burkman; Joseph B Shrager; Leonard A Allmond; Hansell H Stedman Journal: Mol Biol Evol Date: 2002-04 Impact factor: 16.240
Authors: S Zhou; J D Schuetz; K D Bunting; A M Colapietro; J Sampath; J J Morris; I Lagutina; G C Grosveld; M Osawa; H Nakauchi; B P Sorrentino Journal: Nat Med Date: 2001-09 Impact factor: 53.440
Authors: Dov Shiffman; Ellen S O'Meara; Lance A Bare; Charles M Rowland; Judy Z Louie; Andre R Arellano; Thomas Lumley; Kenneth Rice; Olga Iakoubova; May M Luke; Bradford A Young; Mary J Malloy; John P Kane; Stephen G Ellis; Russell P Tracy; James J Devlin; Bruce M Psaty Journal: Arterioscler Thromb Vasc Biol Date: 2007-11-01 Impact factor: 8.311
Authors: Cara L Carty; Petra Buzková; Myriam Fornage; Nora Franceschini; Shelley Cole; Gerardo Heiss; Lucia A Hindorff; Barbara V Howard; Sue Mann; Lisa W Martin; Ying Zhang; Tara C Matise; Ross Prentice; Alexander P Reiner; Charles Kooperberg Journal: Circ Cardiovasc Genet Date: 2012-03-08
Authors: Jose Gutierrez; Sebastian Koch; Chuanhui Dong; Teresita Casanova; Royya Modir; Michael Katsnelson; Gustavo A Ortiz; Ralph L Sacco; Jose G Romano; Tatjana Rundek Journal: Neurol Sci Date: 2013-10-15 Impact factor: 3.307
Authors: Yair Anikster; Tobias B Haack; Thierry Vilboux; Ben Pode-Shakked; Beat Thöny; Nan Shen; Virginia Guarani; Thomas Meissner; Ertan Mayatepek; Friedrich K Trefz; Dina Marek-Yagel; Aurora Martinez; Edward L Huttlin; Joao A Paulo; Riccardo Berutti; Jean-François Benoist; Apolline Imbard; Imen Dorboz; Gali Heimer; Yuval Landau; Limor Ziv-Strasser; May Christine V Malicdan; Corinne Gemperle-Britschgi; Kirsten Cremer; Hartmut Engels; David Meili; Irene Keller; Rémy Bruggmann; Tim M Strom; Thomas Meitinger; James C Mullikin; Gerard Schwartz; Bruria Ben-Zeev; William A Gahl; J Wade Harper; Nenad Blau; Georg F Hoffmann; Holger Prokisch; Thomas Opladen; Manuel Schiff Journal: Am J Hum Genet Date: 2017-01-26 Impact factor: 11.025
Authors: Hyerim Kim; Junghwa Lim; Han Bao; Bin Jiao; Se Min Canon; Michael P Epstein; Keqin Xu; Jie Jiang; Janani Parameswaran; Yingjie Li; Kenneth H Moberg; John E Landers; Christina Fournier; Emily G Allen; Jonathan D Glass; Thomas S Wingo; Peng Jin Journal: Hum Mol Genet Date: 2019-07-15 Impact factor: 6.150
Authors: May M Luke; Wolfgang Lalouschek; Charles M Rowland; Joseph J Catanese; Joel I Bolonick; Nam D Bui; Stefan Greisenegger; Georg Endler; James J Devlin; Christine Mannhalter Journal: Cerebrovasc Dis Date: 2009-09-12 Impact factor: 2.762